In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure.
about
Myocardial Dysfunction and Shock after Cardiac ArrestMitochondrial dysfunction in heart failureIncreased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathwaysTNF-alpha dilates cerebral arteries via NAD(P)H oxidase-dependent Ca2+ spark activationNutritional and anti-inflammatory interventions in chronic heart failure.Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imagingInteraction of TNF with angiotensin II contributes to mitochondrial oxidative stress and cardiac damage in ratsOxidative stress contributes to orthopedic trauma-induced acute kidney injury in obese rats.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disordersCombined therapeutic effects of low power laser (980nm) and CoQ10 on Neuropathic Pain in adult male rat.Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications.Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart FailureExenatide Reduces Tumor Necrosis Factor-α-induced Apoptosis in Cardiomyocytes by Alleviating Mitochondrial Dysfunction.Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.Mitochondria in cardiac hypertrophy and heart failure.TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction.TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload.Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.Soluble tumor necrosis factor receptors and heart failure risk in older adults: Health, Aging, and Body Composition (Health ABC) StudyPhospholipase C as a potential target for cardioprotection during oxidative stress.Diabetic microvascular complications: possible targets for improved macrovascular outcomesTNF-α signaling in Fanconi anemia.Improvement of chronic heart failure by dexamethasone is not associated with downregulation of leptin in rats.Left ventricular systolic dysfunction induced by ventricular ectopy: a novel model for premature ventricular contraction-induced cardiomyopathy.Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.Niemann-Pick type C2 deficiency impairs autophagy-lysosomal activity, mitochondrial function, and TLR signaling in adipocytes.Metabolic remodelling in hypertrophied and failing myocardium: a review.TNFR2 Stimulation Promotes Mitochondrial Fusion via Stat3- and NF-kB-Dependent Activation of OPA1 Expression.Knockdown of TNF-α by DNAzyme gold nanoparticles as an anti-inflammatory therapy for myocardial infarctionTNFα Modulates Cardiac Conduction by Altering Electrical Coupling between Myocytes.A comparison of etanercept vs. infliximab for the treatment of post-arrest myocardial dysfunction in a swine model of ventricular fibrillation.Cardioprotection afforded by NF-kappaB ablation is associated with activation of Akt in mice overexpressing TNF-alpha.Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation.Role of cardiac inflammation in right ventricular failure.Increased Na+,K+-ATPase activity in the rat brain after meningitis induction by Streptococcus pneumoniae.Sequential radial and circumferential strain and oxidative stress assessment in dogs with tachycardia-induced cardiac dysfunction.Muscle endurance, cancer-related fatigue, and radiotherapy in prostate cancer survivors.Regulation of cardiac microRNAs induced by aerobic exercise training during heart failure.Skeletal muscle bioenergetics in aging and heart failure.Tumor necrosis factor-α and its role as a mediator in myocardial infarction: A brief review.
P2860
Q26784080-71207C83-5EA2-4A9F-B214-9A01847F33F7Q26851293-372C71DE-4FF3-43C9-A2F0-3BED8E1F4055Q28385804-E40BA987-8322-46B1-9233-02368DB0E07BQ33226492-788BE523-E438-4A44-8DC7-9B1753000AB0Q33880185-70C000F6-23A1-4A41-A27E-246CA12C0547Q34212330-DFF5EB0A-2FE9-41F2-B9FF-114E6CE75362Q34441654-B7870AFE-BB8F-48AC-B4CF-E62D16DE75C9Q35115779-2AC0FD27-D475-453F-87DA-EF49051AA79FQ35246024-CF50602C-AE67-45BF-AFE1-776570170E29Q35431351-2D1E57C5-D9D2-469C-8778-6388134A355FQ36050486-43FF9183-A4D8-4212-A423-DECF7B0123DEQ36246354-3AF9679D-CC8A-4714-A91E-E26BEB65519CQ36694694-6A42605B-5B00-4349-BA95-115EF975F89DQ37090864-D5393399-6124-4D7F-BD1E-2A885F3EB304Q37246892-ABE088D5-439D-4A0C-9280-68368271B44EQ37326617-1C218889-B236-461A-9D67-E90B576D3EE7Q37406326-E5E19354-3EED-4444-AF86-4B1E365DB2FFQ37601041-FC4D4DBC-3D4E-4542-B24A-3ABD0F57CA9BQ37708944-38DE0392-3A93-416C-9C69-CB214D303AF5Q37731344-4B5754C4-A814-4E12-AACD-4F64991C737FQ37892915-4663B7F5-4E5D-4D22-8147-A1194CF79E37Q38124483-1B485001-3107-434A-9925-6A66C2A49CF0Q38305540-A1B02AB6-B9F5-4C76-8A80-277FA516E7D0Q38506819-EFAFC683-4AB4-44AA-A923-248A777D3596Q38663003-FF1B0B4A-96F6-451C-A9E1-B3F4FE4CE033Q38758703-3113F2B1-1E02-4C0D-872B-54E6E778C017Q39395331-6A1753AD-5E50-43A4-A358-86229EB3BF85Q41239818-FE8C2C9E-2085-4030-9432-AF78A70CD554Q41468713-24EC760E-556B-4B81-A064-9BBA48A9DE5CQ42128515-F14D9E1E-916D-43AE-B2A5-5A8D35167BA6Q42150024-8FB76041-EF63-4EB6-BDEB-BEC0F00B9FBBQ42484804-E1A8B28C-F48E-4107-8BB1-59E1562C4328Q43065625-4BE35FBE-296D-4FD1-9D0A-D94675A71E02Q45068688-6882E309-6368-40E6-8977-F0E29889C2C5Q48359486-50F82CD0-BE6D-4903-889C-DB62B944EDF3Q48640375-3C487B4B-188E-4412-B22F-3E3D2B261358Q48914571-BDCF2D55-3374-4115-BEC9-A19F3453ABE4Q53337219-E8765812-97E4-48DE-AFDF-22BB60178FE3Q54917997-44ECE70A-1B38-4ED1-9FC6-FE79078F7241Q54953158-95A0BBDD-A23D-48B7-A1E5-7A4B6D097A8A
P2860
In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
In vivo TNF-alpha inhibition a ...... in experimental heart failure.
@en
In vivo TNF-alpha inhibition a ...... in experimental heart failure.
@nl
type
label
In vivo TNF-alpha inhibition a ...... in experimental heart failure.
@en
In vivo TNF-alpha inhibition a ...... in experimental heart failure.
@nl
prefLabel
In vivo TNF-alpha inhibition a ...... in experimental heart failure.
@en
In vivo TNF-alpha inhibition a ...... in experimental heart failure.
@nl
P2093
P2860
P1476
In vivo TNF-alpha inhibition a ...... in experimental heart failure.
@en
P2093
Andrea Konig
Gordon W Moe
Jose Marin-Garcia
Michael Goldenthal
Qingping Feng
Xiangru Lu
P2860
P304
P356
10.1152/AJPHEART.00036.2004
P577
2004-06-17T00:00:00Z